Onesource Specialty Pharma Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has issued a notice to Onesource Specialty Pharma for not complying on time with SEBI Listing Regulation 19(1)/19(2), which relates to the composition and functioning of the Nomination and Remuneration Committee, for the quarter ending March 31, 2025. The company was non-compliant for 33 days, attracting a fine of Rs. 2,000 per day, totalling Rs. 66,000 plus 18% GST, making the total payable Rs. 77,880. The company has 15 days to pay the fine or file a waiver application, and must place this matter and the Board's comments before the next board meeting. The fine will keep increasing every day until compliance is achieved.
The immediate financial hit is small at under Rs. 80,000, but it signals governance or compliance weaknesses. If not resolved, NSE could freeze promoter shareholdings or shift the stock to the 'Z' category (trade-for-trade), which would seriously hurt liquidity and investor sentiment.